Fundz

S Engine Precision Medicine reported raising $8.65 Million in an initial SEC Form D filing, from an offering of $3.58 Million

PRIVATEMar 10, 2023

Amount Raised

$8.65 Million

$8.65 Million sold, per SEC Form D (first sale Feb 24, 2023)

Round Type

Series A

SeattleBiotechnology

Quick answer

SEngine Precision Medicine, Inc. raised $8.65 Million in a Series A round, dated February 24, 2023. SEngine Precision Medicine, Inc. is based in Seattle, Washington, United States.

How much did SEngine Precision Medicine, Inc. raise?
SEngine Precision Medicine, Inc. raised $8.65 Million in a Series A round on February 24, 2023.
What does SEngine Precision Medicine, Inc. do?
SEngine Precision Medicine brings the latest advances in cancer research and treatment to the fight against cancer.
Where is SEngine Precision Medicine, Inc. based and how big is it?
SEngine Precision Medicine, Inc. is based in Seattle, Washington, United States.
Who are the decision-makers at SEngine Precision Medicine, Inc?
Fundz holds 1 contact at SEngine Precision Medicine, Inc., including the Executive Officer, Director, Promoter. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as SEngine Precision Medicine, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • CTRL Therapeutics raised $10M (Seed) on April 10, 2023.
  • SenesTech raised $1.5M (Seed) on April 10, 2023.
  • DiaMedica Therapeutics raised $750K (Seed) on April 10, 2023.
  • PTC Therapeutics raised $36M on April 10, 2023.
  • Purinomia Biotech, Inc. raised $500K (Seed) on April 7, 2023.
  • Annovis Bio raised $1.1M (Seed) on April 7, 2023.

Who to call at SEngine Precision Medicine, Inc., and when

A new round usually means SEngine Precision Medicine, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SEngine Precision Medicine, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SEngine Precision Medicine, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SEngine Precision Medicine, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SEngine Precision Medicine, Inc.

Location

401 TERRY AVE N.

Seattle, Washington, United States

About

SEngine Precision Medicine brings the latest advances in cancer research and treatment to the fight against cancer. With a focus on functional screening, genomics, robotics, cancer organoid cultures, and bioinformatics, SEngine Precision Medicine is providing invaluable data to oncologists and realizing the promise of precise, less toxic and more effective therapies to cancer patients. The accumulation of data is essential to pharmaceutical companies to accelerate the success of cancer treatments. SEngine is CLIA certified to receive your sample today.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SEngine Precision Medicine, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsCarla G., Executive Officer, Director, PromoterSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for SEngine Precision Medicine, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

SEngine Precision Medicine, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.